Vitamin D and Diabetes
Tóm tắt
Từ khóa
Tài liệu tham khảo
2009
LeRoith, 2002, Beta-cell dysfunction and insulin resistance in type 2 diabetes: role of metabolic and genetic abnormalities, Am J Med, 113, 3S, 10.1016/S0002-9343(02)01276-7
Knip, 2008, Autoimmune mechanisms in type 1 diabetes, Autoimmun Rev, 7, 550, 10.1016/j.autrev.2008.04.008
Palomer, 2008, Role of vitamin D in the pathogenesis of type 2 diabetes mellitus, Diabetes Obes Metab, 10, 185, 10.1111/j.1463-1326.2007.00710.x
Wilkin, 2007, Changing perspectives in diabetes: their impact on its classification, Diabetologia, 50, 1587, 10.1007/s00125-007-0665-5
Resmini, 2009, Secondary diabetes associated with principal endocrinopathies: the impact of new treatment modalities, Acta Diabetol, 46, 85, 10.1007/s00592-009-0112-9
Bouillon, 2008, Vitamin D and human health: lessons from vitamin D receptor null mice, Endocr Rev, 29, 726, 10.1210/er.2008-0004
Nyomba, 1986, Pancreatic secretion in man with subclinical vitamin D deficiency, Diabetologia, 29, 34, 10.1007/BF02427278
Barrett, 2009, Genome-wide association study and meta-analysis find that over 40 loci affect risk of type 1 diabetes, Nat Genet, 41, 703, 10.1038/ng.381
Steck, 2009, Do non-HLA genes influence development of persistent islet autoimmunity and type 1 diabetes in children with high-risk HLA-DR, DQ genotypes?, Diabetes, 58, 1028, 10.2337/db08-1179
Lopez, 2004, CYP27B1 polymorphisms variants are associated with type 1 diabetes mellitus in Germans, J Steroid Biochem Mol Biol, 89–90, 155, 10.1016/j.jsbmb.2004.03.095
Pani, 2002, Vitamin D 1alpha-hydroxylase (CYP1alpha) polymorphism in Graves' disease, Hashimoto's thyroiditis and type 1 diabetes mellitus, Eur J Endocrinol, 146, 777, 10.1530/eje.0.1460777
Bailey, 2007, Association of the vitamin D metabolism gene CYP27B1 with type 1 diabetes, Diabetes, 56, 2616, 10.2337/db07-0652
Ogunkolade, 2002, Vitamin D receptor (VDR) mRNA and VDR protein levels in relation to vitamin D status, insulin secretory capacity, and VDR genotype in Bangladeshi Asians, Diabetes, 51, 2294, 10.2337/diabetes.51.7.2294
van Etten, 2007, The vitamin D receptor gene FokI polymorphism: functional impact on the immune system, Eur J Immunol, 37, 395, 10.1002/eji.200636043
Garcia, 2007, VDR polymorphisms influence the immune response in type 1 diabetic children from Santiago, Chile, Diabetes Res Clin Pract, 77, 134, 10.1016/j.diabres.2006.10.018
Pani, 2000, Vitamin D receptor allele combinations influence genetic susceptibility to type 1 diabetes in Germans, Diabetes, 49, 504, 10.2337/diabetes.49.3.504
Chang, 2000, Vitamin D receptor gene polymorphisms influence susceptibility to type 1 diabetes mellitus in the Taiwanese population, Clin Endocrinol (Oxf), 52, 575, 10.1046/j.1365-2265.2000.00985.x
Guo, 2006, Meta-analysis of vitamin D receptor polymorphisms and type 1 diabetes: a HuGE review of genetic association studies, Am J Epidemiol, 164, 711, 10.1093/aje/kwj278
Lemos, 2008, Lack of association of vitamin D receptor gene polymorphisms with susceptibility to type 1 diabetes mellitus in the Portuguese population, Hum Immunol, 69, 134, 10.1016/j.humimm.2008.01.008
Turpeinen, 2003, Vitamin D receptor polymorphisms: no association with type 1 diabetes in the Finnish population, Eur J Endocrinol, 149, 591, 10.1530/eje.0.1490591
Israni, 2009, Interaction of vitamin D receptor with HLA DRB1 0301 in type 1 diabetes patients from North India, PLoS One, 4, e8023, 10.1371/journal.pone.0008023
Karvonen, 2000, Incidence of childhood type 1 diabetes worldwide. Diabetes Mondiale (DiaMond) Project Group, Diabetes Care, 23, 1516, 10.2337/diacare.23.10.1516
1988, Geographic patterns of childhood insulin-dependent diabetes mellitus. Diabetes Epidemiology Research International Group, Diabetes, 37, 1113, 10.2337/diabetes.37.8.1113
Sloka, 2010, The geospatial relation between UV solar radiation and type 1 diabetes in Newfoundland, Acta Diabetol, 47, 73, 10.1007/s00592-009-0100-0
Staples, 2003, Ecologic analysis of some immune-related disorders, including type 1 diabetes, in Australia: latitude, regional ultraviolet radiation, and disease prevalence, Environ Health Perspect, 111, 518, 10.1289/ehp.5941
Cantorna, 2004, Mounting evidence for vitamin D as an environmental factor affecting autoimmune disease prevalence, Exp Biol Med (Maywood), 229, 1136, 10.1177/153537020422901108
Mohr, 2008, The association between ultraviolet B irradiance, vitamin D status and incidence rates of type 1 diabetes in 51 regions worldwide, Diabetologia, 51, 1391, 10.1007/s00125-008-1061-5
Karvonen, 1998, Comparison of the seasonal pattern in the clinical onset of IDDM in Finland and Sardinia, Diabetes Care, 21, 1101, 10.2337/diacare.21.7.1101
Neu, 1997, Incidence of IDDM in German children aged 0-14 years. A 6-year population-based study (1987–1993), Diabetes Care, 20, 530, 10.2337/diacare.20.4.530
Kahn, 2009, Association of type 1 diabetes with month of birth among U.S. youth: the SEARCH for Diabetes in Youth Study, Diabetes Care, 32, 2010, 10.2337/dc09-0891
Bouillon, 1995, Verh K Acad Geneeskd Belg, 57, 371
Provvedini, 1983, 1,25-dihydroxyvitamin D3 receptors in human leukocytes, Science, 221, 1181, 10.1126/science.6310748
Veldman, 2000, Expression of 1,25-dihydroxyvitamin D3 receptor in the immune system, Arch Biochem Biophys, 374, 334, 10.1006/abbi.1999.1605
Dong, 2005, Regulation of relB in dendritic cells by means of modulated association of vitamin D receptor and histone deacetylase 3 with the promoter, Proc Natl Acad Sci U S A, 102, 16007, 10.1073/pnas.0506516102
Muthian, 2006, 1,25 Dihydroxyvitamin-D3 modulates JAK-STAT pathway in IL-12/IFNgamma axis leading to Th1 response in experimental allergic encephalomyelitis, J Neurosci Res, 83, 1299, 10.1002/jnr.20826
Guery, 1995, Dendritic cells are the most efficient in presenting endogenous naturally processed self-epitopes to class II-restricted T cells, J Immunol, 154, 536, 10.4049/jimmunol.154.2.536
Schwartz, 1990, A cell culture model for T lymphocyte clonal anergy, Science, 248, 1349, 10.1126/science.2113314
Griffin, 2000, Potent inhibition of dendritic cell differentiation and maturation by vitamin D analogs, Biochem Biophys Res Commun, 270, 701, 10.1006/bbrc.2000.2490
van Halteren, 2002, Redirection of human autoreactive T-cells upon interaction with dendritic cells modulated by TX527, an analog of 1,25 dihydroxyvitamin D3, Diabetes, 51, 2119, 10.2337/diabetes.51.7.2119
van Etten, 2004, 1,25-Dihydroxyvitamin D3 alters the profile of bone marrow-derived dendritic cells of NOD mice, Ann N Y Acad Sci, 1037, 186, 10.1196/annals.1337.030
Penna, 2000, 1 Alpha,25-dihydroxyvitamin D3 inhibits differentiation, maturation, activation, and survival of dendritic cells leading to impaired alloreactive T cell activation, J Immunol, 164, 2405, 10.4049/jimmunol.164.5.2405
van Halteren, 2004, 1alpha,25-dihydroxyvitamin D3 or analogue treated dendritic cells modulate human autoreactive T cells via the selective induction of apoptosis, J Autoimmun, 23, 233, 10.1016/j.jaut.2004.06.004
Ferreira, 2009, Proteome analysis demonstrates profound alterations in human dendritic cell nature by TX527, an analogue of vitamin D, Proteomics, 9, 3752, 10.1002/pmic.200800848
Adorini, 2003, Tolerogenic dendritic cells induced by vitamin D receptor ligands enhance regulatory T cells inhibiting autoimmune diabetes, Ann N Y Acad Sci, 987, 258, 10.1111/j.1749-6632.2003.tb06057.x
Penna, 2005, Expression of the inhibitory receptor ILT3 on dendritic cells is dispensable for induction of CD4+Foxp3+ regulatory T cells by 1,25-dihydroxyvitamin D3, Blood, 106, 3490, 10.1182/blood-2005-05-2044
Bhalla, 1984, 1,25-Dihydroxyvitamin D3 inhibits antigen-induced T cell activation, J Immunol, 133, 1748, 10.4049/jimmunol.133.4.1748
Rigby, 1984, Inhibition of T lymphocyte mitogenesis by 1,25-dihydroxyvitamin D3 (calcitriol), J Clin Invest, 74, 1451, 10.1172/JCI111557
Nunn, 1986, Regulation of human tonsillar T-cell proliferation by the active metabolite of vitamin D3, Immunology, 59, 479
Matsui, 1985, 1,25-Dihydroxyvitamin D3 regulates proliferation of activated T-lymphocyte subsets, Life Sci, 37, 95, 10.1016/0024-3205(85)90630-7
Rigby, 1987, Regulation of lymphokine production and human T lymphocyte activation by 1,25-dihydroxyvitamin D3. Specific inhibition at the level of messenger RNA, J Clin Invest, 79, 1659, 10.1172/JCI113004
Boonstra, 2001, 1alpha,25-Dihydroxyvitamin D3 has a direct effect on naïve CD4(+) T cells to enhance the development of Th2 cells, J Immunol, 167, 4974, 10.4049/jimmunol.167.9.4974
Willheim, 1999, Regulatory effects of 1alpha,25-dihydroxyvitamin D3 on the cytokine production of human peripheral blood lymphocytes, J Clin Endocrinol Metab, 84, 3739, 10.1210/jc.84.10.3739
Gregori, 2002, 1alpha,25-dihydroxyvitamin D3 analog enhances regulatory T-cells and arrests autoimmune diabetes in NOD mice, Diabetes, 51, 1367, 10.2337/diabetes.51.5.1367
Ghoreishi, 2009, Expansion of antigen-specific regulatory T cells with the topical vitamin D analog calcipotriol, J Immunol, 182, 6071, 10.4049/jimmunol.0804064
Hewison, 2001, Vitamin D as a cytokine and hematopoetic factor, Rev Endocr Metab Disord, 2, 217, 10.1023/A:1010015013211
Baeke, 2008, Vitamin D signaling in immune-mediated disorders: evolving insights and therapeutic opportunities, Mol Aspects Med, 29, 376, 10.1016/j.mam.2008.05.004
Jeffery, 2009, 1,25-Dihydroxyvitamin D3 and IL-2 combine to inhibit T cell production of inflammatory cytokines and promote development of regulatory T cells expressing CTLA-4 and FoxP3, J Immunol, 183, 5458, 10.4049/jimmunol.0803217
Chen, 2007, Modulatory effects of 1,25-dihydroxyvitamin D3 on human B cell differentiation, J Immunol, 179, 1634, 10.4049/jimmunol.179.3.1634
Shiozawa, 1987, 1 alpha,25-Dihydroxyvitamin D3 inhibits proliferative response of T- and B-lymphocytes in a serum-free culture, Int J Immunopharmacol, 9, 719, 10.1016/0192-0561(87)90043-9
Imazeki, 2006, Immunomodulating effect of vitamin D3 derivatives on type-1 cellular immunity, Biomed Res, 27, 1, 10.2220/biomedres.27.1
van Etten, 2005, Immunoregulation by 1,25-dihydroxyvitamin D3: basic concepts, J Steroid Biochem Mol Biol, 97, 93, 10.1016/j.jsbmb.2005.06.002
Sia, 2005, Imbalance in Th cell polarization and its relevance in type 1 diabetes mellitus, Rev Diabet Stud, 2, 182, 10.1900/RDS.2005.2.182
Flores, 2005, A role of vitamin D in low-intensity chronic inflammation and insulin resistance in type 2 diabetes mellitus?, Nutr Res Rev, 18, 175, 10.1079/NRR2005104
Eizirik, 2008, The role for endoplasmic reticulum stress in diabetes mellitus, Endocr Rev, 29, 42, 10.1210/er.2007-0015
Hahn, 1997, 1,25-Dihydroxyvitamin D3 reduces MHC antigen expression on pancreatic beta-cells in vitro, Transplant Proc, 29, 2156, 10.1016/S0041-1345(97)00273-X
Riachy, 2002, 1,25-dihydroxyvitamin D3 protects RINm5F and human islet cells against cytokine-induced apoptosis: implication of the antiapoptotic protein A20, Endocrinology, 143, 4809, 10.1210/en.2002-220449
Riachy, 2006, 1,25-Dihydroxyvitamin D3 protects human pancreatic islets against cytokine-induced apoptosis via down-regulation of the Fas receptor, Apoptosis, 11, 151, 10.1007/s10495-006-3558-z
Gysemans, 2005, 1,25-Dihydroxyvitamin D3 modulates expression of chemokines and cytokines in pancreatic islets: implications for prevention of diabetes in nonobese diabetic mice, Endocrinology, 146, 1956, 10.1210/en.2004-1322
Mathieu, 1994, Prevention of autoimmune diabetes in NOD mice by 1,25 dihydroxyvitamin D3, Diabetologia, 37, 552, 10.1007/BF00403372
Mathieu, 1992, 1,25-Dihydroxyvitamin D3 prevents insulitis in NOD mice, Diabetes, 41, 1491, 10.2337/diabetes.41.11.1491
Decallonne, 2005, 1Alpha,25-dihydroxyvitamin D3 restores thymocyte apoptosis sensitivity in non-obese diabetic (NOD) mice through dendritic cells, J Autoimmun, 24, 281, 10.1016/j.jaut.2005.03.007
Casteels, 1998, 1,25-Dihydroxyvitamin D3 restores sensitivity to cyclophosphamide-induced apoptosis in non-obese diabetic (NOD) mice and protects against diabetes, Clin Exp Immunol, 112, 181, 10.1046/j.1365-2249.1998.00568.x
Mathieu, 1995, Prevention of type I diabetes in NOD mice by nonhypercalcemic doses of a new structural analog of 1,25-dihydroxyvitamin D3, KH1060, Endocrinology, 136, 866, 10.1210/en.136.3.866
Del Pino-Montes, 2004, Calcitriol improves streptozotocin-induced diabetes and recovers bone mineral density in diabetic rats, Calcif Tissue Int, 75, 526, 10.1007/s00223-004-0118-9
Keymeulen, 2005, Insulin needs after CD3-antibody therapy in new-onset type 1 diabetes, N Engl J Med, 352, 2598, 10.1056/NEJMoa043980
Casteels, 1998, Prevention of autoimmune destruction of syngeneic islet grafts in spontaneously diabetic nonobese diabetic mice by a combination of a vitamin D3 analog and cyclosporine, Transplantation, 65, 1225, 10.1097/00007890-199805150-00014
Mathieu, 2001, In vitro and in vivo analysis of the immune system of vitamin D receptor knockout mice, J Bone Miner Res, 16, 2057, 10.1359/jbmr.2001.16.11.2057
Gysemans, 2002, Treatment of autoimmune diabetes recurrence in non-obese diabetic mice by mouse interferon-beta in combination with an analogue of 1alpha,25-dihydroxyvitamin-D3, Clin Exp Immunol, 128, 213, 10.1046/j.1365-2249.2002.01825.x
Zeitz, 2003, Impaired insulin secretory capacity in mice lacking a functional vitamin D receptor, FASEB J, 17, 509, 10.1096/fj.02-0424fje
Gysemans, 2008, Unaltered diabetes presentation in NOD mice lacking the vitamin D receptor, Diabetes, 57, 269, 10.2337/db07-1095
Hypponen, 2001, Intake of vitamin D and risk of type 1 diabetes: a birth-cohort study, Lancet, 358, 1500, 10.1016/S0140-6736(01)06580-1
Stene, 2000, Use of cod liver oil during pregnancy associated with lower risk of type I diabetes in the offspring, Diabetologia, 43, 1093, 10.1007/s001250051499
Stene, 2003, Use of cod liver oil during the first year of life is associated with lower risk of childhood-onset type 1 diabetes: a large, population-based, case-control study, Am J Clin Nutr, 78, 1128, 10.1093/ajcn/78.6.1128
1999, Vitamin D supplement in early childhood and risk for type I (insulin-dependent) diabetes mellitus. The EURODIAB Substudy 2 Study Group, Diabetologia, 42, 51, 10.1007/s001250051112
Zipitis, 2008, Vitamin D supplementation in early childhood and risk of type 1 diabetes: a systematic review and meta-analysis, Arch Dis Child, 93, 512, 10.1136/adc.2007.128579
Fronczak, 2003, In utero dietary exposures and risk of islet autoimmunity in children, Diabetes Care, 26, 3237, 10.2337/diacare.26.12.3237
Wicklow, 2006, Feasibility of a type 1 diabetes primary prevention trial using 2000 IU vitamin D3 in infants from the general population with increased HLA-associated risk, Ann N Y Acad Sci, 1079, 310, 10.1196/annals.1375.047
Pitocco, 2006, The effects of calcitriol and nicotinamide on residual pancreatic beta-cell function in patients with recent-onset Type 1 diabetes (IMDIAB XI), Diabet Med, 23, 920, 10.1111/j.1464-5491.2006.01921.x
Pozzilli, 2001, Autoimmune diabetes not requiring insulin at diagnosis (latent autoimmune diabetes of the adult): definition, characterization, and potential prevention, Diabetes Care, 24, 1460, 10.2337/diacare.24.8.1460
Li, 2009, Protective effects of 1-alpha-hydroxyvitamin D3 on residual beta-cell function in patients with adult-onset latent autoimmune diabetes (LADA), Diabetes Metab Res Rev, 25, 411, 10.1002/dmrr.977
Pittas, 2009, Association between serum osteocalcin and markers of metabolic phenotype, J Clin Endocrinol Metab, 94, 827, 10.1210/jc.2008-1422
Guillausseau, 2008, Abnormalities in insulin secretion in type 2 diabetes mellitus, Diabetes Metab, 34, S43, 10.1016/S1262-3636(08)73394-9
Zimmet, 2001, Global and societal implications of the diabetes epidemic, Nature, 414, 782, 10.1038/414782a
Zittermann, 2003, Vitamin D in preventive medicine: are we ignoring the evidence?, Br J Nutr, 89, 552, 10.1079/BJN2003837
Scragg, 2008, Vitamin D and type 2 diabetes: are we ready for a prevention trial?, Diabetes, 57, 2565, 10.2337/db08-0879
Scragg, 2004, Serum 25-hydroxyvitamin D, diabetes, and ethnicity in the third national health and nutrition examination survey, Diabetes care, 27, 2813, 10.2337/diacare.27.12.2813
Chiu, 2004, Hypovitaminosis D is associated with insulin resistance and beta cell dysfunction, Am J Clin Nutr, 79, 820, 10.1093/ajcn/79.5.820
Ford, 2005, Concentrations of serum vitamin D and the metabolic syndrome among U.S. adults, Diabetes Care, 28, 1228, 10.2337/diacare.28.5.1228
Forouhi, 2007, Incidence of Type 2 diabetes in England and its association with baseline impaired fasting glucose: the Ely study 1990–2000, Diabet Med, 24, 200, 10.1111/j.1464-5491.2007.02068.x
Clark, 1981, Effect of 1,25 dihydroxyvitamin D3 on insulin secretion, Diabetes, 30, 382, 10.2337/diabetes.30.5.382
Boucher, 1998, Inadequate vitamin D status: does it contribute to the disorders comprising syndrome ‘X’?, Br J Nutr, 79, 315, 10.1079/BJN19980055
Cigolini, 2006, Serum 25-hydroxyvitamin D3 concentrations and prevalence of cardiovascular disease among type 2 diabetic patients, Diabetes care, 29, 722, 10.2337/diacare.29.03.06.dc05-2148
Giulietti, 2007, Monocytes from type 2 diabetic patients have a pro-inflammatory profile. 1,25-Dihydroxyvitamin D(3) works as anti-inflammatory, Diabetes Res Clin Pract, 77, 47, 10.1016/j.diabres.2006.10.007
DeFronzo, 2009, Skeletal muscle insulin resistance is the primary defect in type 2 diabetes, Diabetes Care, 32, S157, 10.2337/dc09-S302
Boucher, 2009, Does vitamin D status contribute to caveolin-1-mediated insulin sensitivity in skeletal muscle?, Diabetologia, 52, 2240, 10.1007/s00125-009-1478-5
Oh, 2008, A potential role for skeletal muscle caveolin-1 as an insulin sensitivity modulator in ageing-dependent non-obese type 2 diabetes: studies in a new mouse model, Diabetologia, 51, 1025, 10.1007/s00125-008-0993-0
Huhtakangas, 2004, The vitamin D receptor is present in caveolae-enriched plasma membranes and binds 1 alpha,25(OH)2-vitamin D3 in vivo and in vitro, Mol Endocrinol, 18, 2660, 10.1210/me.2004-0116
Malecki, 2005, Genetics of type 2 diabetes mellitus, Diabetes Res Clin Pract, 68, S10, 10.1016/j.diabres.2005.03.003
Hirai, 2000, Variations in vitamin D-binding protein (group-specific component protein) are associated with fasting plasma insulin levels in Japanese with normal glucose tolerance, J Clin Endocrinol Metab, 85, 1951, 10.1210/jc.85.5.1951
Hirai, 1998, Group specific component protein genotype is associated with NIDDM in Japan, Diabetologia, 41, 742, 10.1007/s001250050980
Klupa, 1999, Amino acid variants of the vitamin D-binding protein and risk of diabetes in white Americans of European origin, Eur J Endocrinol, 141, 490, 10.1530/eje.0.1410490
Malecki, 2002, Vitamin D binding protein gene and genetic susceptibility to type 2 diabetes mellitus in a Polish population, Diabetes Res Clin Pract, 57, 99, 10.1016/S0168-8227(02)00020-7
Sinotte, 2009, Genetic polymorphisms of the vitamin D binding protein and plasma concentrations of 25-hydroxyvitamin D in premenopausal women, Am J Clin Nutr, 89, 634, 10.3945/ajcn.2008.26445
Uitterlinden, 2004, Vitamin D receptor gene polymorphisms in relation to Vitamin D related disease states, J Steroid Biochem Mol Biol, 89–90, 187, 10.1016/j.jsbmb.2004.03.083
Uitterlinden, 2004, Genetics and biology of vitamin D receptor polymorphisms, Gene, 338, 143, 10.1016/j.gene.2004.05.014
Valdivielso, 2006, Vitamin D receptor polymorphisms and diseases, Clin Chim Acta, 371, 1, 10.1016/j.cca.2006.02.016
Oh, 2002, Association between vitamin D receptor polymorphism and type 2 diabetes or metabolic syndrome in community-dwelling older adults: the Rancho Bernardo Study, Metabolism, 51, 356, 10.1053/meta.2002.29969
Ortlepp, 2003, The vitamin D receptor gene variant and physical activity predicts fasting glucose levels in healthy young men, Diabet Med, 20, 451, 10.1046/j.1464-5491.2003.00971.x
Filus, 2008, Relationship between vitamin D receptor BsmI and FokI polymorphisms and anthropometric and biochemical parameters describing metabolic syndrome, Aging Male, 11, 134, 10.1080/13685530802273426
Ye, 2001, Vitamin D receptor gene polymorphisms are associated with obesity in type 2 diabetic subjects with early age of onset, Eur J Endocrinol, 145, 181, 10.1530/eje.0.1450181
Dilmec, 2009, Detection of VDR gene ApaI and TaqI polymorphisms in patients with type 2 diabetes mellitus using PCR-RFLP method in a Turkish population, J Diabetes Complications
Bid, 2009, Vitamin D receptor (FokI, BsmI and TaqI) gene polymorphisms and type 2 diabetes mellitus: a North Indian study, Indian J Med Sci, 63, 187, 10.4103/0019-5359.53164
Malecki, 2003, Vitamin D receptor gene polymorphisms and association with type 2 diabetes mellitus in a Polish population, Exp Clin Endocrinol Diabetes, 111, 505, 10.1055/s-2003-44711
Speer, 2001, Oestrogen and vitamin D receptor (VDR) genotypes and the expression of ErbB-2 and EGF receptor in human rectal cancers, Eur J Cancer, 37, 1463, 10.1016/S0959-8049(01)00139-3
Norman, 1980, Vitamin D deficiency inhibits pancreatic secretion of insulin, Science, 209, 823, 10.1126/science.6250216
Chertow, 1983, Cellular mechanisms of insulin release: the effects of vitamin D deficiency and repletion on rat insulin secretion, Endocrinology, 113, 1511, 10.1210/endo-113-4-1511
Cade, 1986, Vitamin D3 improves impaired glucose tolerance and insulin secretion in the vitamin D-deficient rat in vivo, Endocrinology, 119, 84, 10.1210/endo-119-1-84
Kumar, 1997, Renal diseases in diabetes mellitus, J Indian Med Assoc, 95, 426
Kadowaki, 1984, Risk factors for worsening to diabetes in subjects with impaired glucose tolerance, Diabetologia, 26, 44, 10.1007/BF00252262
Chertow, 1986, Islet insulin release and net calcium retention in vitro in vitamin D-deficient rats, Diabetes, 35, 771, 10.2337/diabetes.35.7.771
Cade, 1987, Rapid normalization/stimulation by 1,25-dihydroxyvitamin D3 of insulin secretion and glucose tolerance in the vitamin D-deficient rat, Endocrinology, 120, 1490, 10.1210/endo-120-4-1490
Ishida, 1983, Effect of 1,25-dihydroxyvitamin D3 on pancreatic B and D cell function, Life Sci, 33, 1779, 10.1016/0024-3205(83)90685-9
d'Emden, 1989, The in vitro effect of 1 alpha,25-dihydroxyvitamin D3 on insulin production by neonatal rat islets, Biochem Biophys Res Commun, 164, 413, 10.1016/0006-291X(89)91735-X
de Boland, 1990, Evidence for involvement of protein kinase C and cyclic adenosine 3′,5′ monophosphate-dependent protein kinase in the 1,25-dihydroxy-vitamin D3-mediated rapid stimulation of intestinal calcium transport, (transcaltachia), Endocrinology, 127, 39, 10.1210/endo-127-1-39
Bourlon, 1997, Modulatory role of 1,25 dihydroxyvitamin D3 on pancreatic islet insulin release via the cyclic AMP pathway in the rat, Br J Pharmacol, 121, 751, 10.1038/sj.bjp.0701204
Hoenderop, 2002, Modulation of renal Ca2+ transport protein genes by dietary Ca2+ and 1,25-dihydroxyvitamin D3 in 25-hydroxyvitamin D3-1alpha-hydroxylase knockout mice, FASEB J, 16, 1398, 10.1096/fj.02-0225com
Milner, 1967, The role of calcium and magnesium in insulin secretion from rabbit pancreas studied in vitro, Diabetologia, 3, 47, 10.1007/BF01269910
Hou, 2009, Insulin granule biogenesis, trafficking and exocytosis, Vitam Horm, 80, 473, 10.1016/S0083-6729(08)00616-X
Rhodes, 1994, What beta-cell defect could lead to hyperproinsulinemia in NIDDM? Some clues from recent advances made in understanding the proinsulin-processing mechanism, Diabetes, 43, 511, 10.2337/diabetes.43.4.511
Hitman, 1998, Vitamin D receptor gene polymorphisms influence insulin secretion in Bangladeshi Asians, Diabetes, 47, 688, 10.2337/diabetes.47.4.688
Munshi, 1996, Ca2+ regulates calmodulin binding to IQ motifs in IRS-1, Biochemistry, 35, 15883, 10.1021/bi962107y
Li, 2000, Binding of IRS proteins to calmodulin is enhanced in insulin resistance, Biochemistry, 39, 5089, 10.1021/bi992623z
McCarty, 2003, PTH excess may promote weight gain by impeding catecholamine-induced lipolysis-implications for the impact of calcium, vitamin D, and alcohol on body weight, Med Hypotheses, 61, 535, 10.1016/S0306-9877(03)00227-5
Lee, 1994, 1,25-Dihydroxyvitamin D3 and pancreatic beta-cell function: vitamin D receptors, gene expression, and insulin secretion, Endocrinology, 134, 1602, 10.1210/en.134.4.1602
Huotari, 1998, Growth factor-mediated proliferation and differentiation of insulin-producing INS-1 and RINm5F cells: identification of betacellulin as a novel beta-cell mitogen, Endocrinology, 139, 1494, 10.1210/en.139.4.1494
Sergeev, 1995, 1,25-Dihydroxyvitamin D3 evokes oscillations of intracellular calcium in a pancreatic beta-cell line, Endocrinology, 136, 2852, 10.1210/en.136.7.2852
Kajikawa, 1999, An insulinotropic effect of vitamin D analog with increasing intracellular Ca2+ concentration in pancreatic beta-cells through nongenomic signal transduction, Endocrinology, 140, 4706, 10.1210/en.140.10.4706
Larsen, 2009, Sustained effects of interleukin-1 receptor antagonist treatment in type 2 diabetes, Diabetes Care, 32, 1663, 10.2337/dc09-0533
Chang-Quan, 2008, Insulin resistance, renal injury, renal 1-alpha hydroxylase, and bone homeostasis in aged obese rats, Arch Med Res, 39, 380, 10.1016/j.arcmed.2007.12.008
Kawashima, 1981, Effect of 1 alpha-hydroxyvitamin D3 on the glucose and calcium metabolism in genetic obese mice, Res Commun Chem Pathol Pharmacol, 33, 155
Anderson, 2009, Renal 25-hydroxycholecalciferol reabsorption is modulated in a type II diabetic rat model, FASEB J, 23, 736, 10.1096/fasebj.23.1_supplement.731.6
de Souza Santos, 2005, Effect of cholecalciferol supplementation on blood glucose in an experimental model of type 2 diabetes mellitus in spontaneously hypertensive rats and Wistar rats, Clin Chim Acta, 358, 146, 10.1016/j.cccn.2005.02.020
Ceylan-Isik, 2007, Cod liver oil supplementation improves cardiovascular and metabolic abnormalities in streptozotocin diabetic rats, J Pharm Pharmacol, 59, 1629, 10.1211/jpp.59.12.0004
Silva, 1996, Effect of treatment with cholecalciferol on the membrane potential and contractility of aortae from spontaneously hypertensive rats, Br J Pharmacol, 118, 1367, 10.1111/j.1476-5381.1996.tb15546.x
Nilas, 1984, Treatment with vitamin D or its analogues does not change body weight or blood glucose level in postmenopausal women, Int J Obes, 8, 407
Inomata, 1986, Effect of 1 alpha (OH)-vitamin D3 on insulin secretion in diabetes mellitus, Bone Miner, 1, 187
Gedik, 1986, Effects of vitamin D deficiency and repletion on insulin and glucagon secretion in man, Diabetologia, 29, 142, 10.1007/BF02427083
Ljunghall, 1987, Treatment with one-alpha-hydroxycholecalciferol in middle-aged men with impaired glucose tolerance—a prospective randomized double-blind study, Acta Med Scand, 222, 361, 10.1111/j.0954-6820.1987.tb10684.x
Kumar, 1994, Improvement in glucose tolerance and beta-cell function in a patient with vitamin D deficiency during treatment with vitamin D, Postgrad Med J, 70, 440, 10.1136/pgmj.70.824.440
Boucher, 1995, Glucose intolerance and impairment of insulin secretion in relation to vitamin D deficiency in east London Asians, Diabetologia, 38, 1239, 10.1007/BF00422375
Allegra, 1994, Glucose-induced insulin secretion in uremia: role of 1 alpha,25(HO)2-vitamin D3, Nephron, 68, 41, 10.1159/000188085
Orwoll, 1994, Effects of vitamin D on insulin and glucagon secretion in non-insulin-dependent diabetes mellitus, Am J Clin Nutr, 59, 1083, 10.1093/ajcn/59.5.1083
Fliser, 1997, No effect of calcitriol on insulin-mediated glucose uptake in healthy subjects, Eur J Clin Invest, 27, 629, 10.1046/j.1365-2362.1997.1520699.x
Taylor, 1998, Vitamin D replacement in Asians with diabetes may increase insulin resistance, Postgrad Med J, 74, 365, 10.1136/pgmj.74.872.365
Borissova, 2003, The effect of vitamin D3 on insulin secretion and peripheral insulin sensitivity in type 2 diabetic patients, Int J Clin Pract, 57, 258, 10.1111/j.1742-1241.2003.tb10480.x
Pittas, 2006, Vitamin D and calcium intake in relation to type 2 diabetes in women, Diabetes care, 29, 650, 10.2337/diacare.29.03.06.dc05-1961
Pittas, 2007, The effects of calcium and vitamin D supplementation on blood glucose and markers of inflammation in nondiabetic adults, Diabetes care, 30, 980, 10.2337/dc06-1994
de Boer, 2008, Calcium plus vitamin D supplementation and the risk of incident diabetes in the Women's Health Initiative, Diabetes Care, 31, 701, 10.2337/dc07-1829
Nagpal, 2009, A double-blind, randomized, placebo-controlled trial of the short-term effect of vitamin D3 supplementation on insulin sensitivity in apparently healthy, middle-aged, centrally obese men, Diabet Med, 26, 19, 10.1111/j.1464-5491.2008.02636.x
Pittas, 2007, The role of vitamin D and calcium in type 2 diabetes. A systematic review and meta-analysis, J Clin Endocrinol Metab, 92, 2017, 10.1210/jc.2007-0298
Knekt, 2008, Serum vitamin D and subsequent occurrence of type 2 diabetes, Epidemiology, 19, 666, 10.1097/EDE.0b013e318176b8ad
von Hurst, 2009, Vitamin D supplementation reduces insulin resistance in South Asian women living in New Zealand who are insulin resistant and vitamin D deficient - a randomised, placebo-controlled trial, Br J Nutr, 103, 549, 10.1017/S0007114509992017
Avenell, 2009, Vitamin D supplementation and type 2 diabetes: a substudy of a randomised placebo-controlled trial in older people (RECORD trial, ISRCTN 51647438), Age Ageing, 38, 606, 10.1093/ageing/afp109
Kazemi, 2009, Insulin receptor gene mutations in Iranian patients with type II diabetes mellitus, Iran Biomed J, 13, 161
Holmes, 2009, Vitamin D deficiency and insufficiency in pregnant women: a longitudinal study, Br J Nutr, 102, 876, 10.1017/S0007114509297236
Maghbooli, 2008, Correlation between vitamin D3 deficiency and insulin resistance in pregnancy, Diabetes Metab Res Rev, 24, 27, 10.1002/dmrr.737
Zhang, 2008, Maternal plasma 25-hydroxyvitamin D concentrations and the risk for gestational diabetes mellitus, PLoS One, 3, e3753, 10.1371/journal.pone.0003753
Lapillonne, 2010, Vitamin D deficiency during pregnancy may impair maternal and fetal outcomes, Med Hypotheses, 74, 71, 10.1016/j.mehy.2009.07.054
Rudnicki, 1997, Effect of 1,25-dihydroxycholecalciferol on glucose metabolism in gestational diabetes mellitus, Diabetologia, 40, 40, 10.1007/s001250050640
Zhang, 2009, Long-term therapeutic effect of vitamin D analog doxercalciferol on diabetic nephropathy: strong synergism with AT1 receptor antagonist, Am J Physiol Renal Physiol, 297, F791, 10.1152/ajprenal.00247.2009
Chonchol, 2007, 25-Hydroxyvitamin D, insulin resistance, and kidney function in the Third National Health and Nutrition Examination Survey, Kidney Int, 71, 134, 10.1038/sj.ki.5002002
Diaz, 2009, The association of vitamin D deficiency and insufficiency with diabetic nephropathy: implications for health disparities, J Am Board Fam Med, 22, 521, 10.3122/jabfm.2009.05.080231
Wolf, 2007, Vitamin D levels and early mortality among incident hemodialysis patients, Kidney Int, 72, 1004, 10.1038/sj.ki.5002451
Aksoy, 2000, Serum 1,25 dihydroxy vitamin D (1,25(OH)2D3), 25 hydroxy vitamin D (25(OH)D) and parathormone levels in diabetic retinopathy, Clin Biochem, 33, 47, 10.1016/S0009-9120(99)00085-5
Parekh, 2007, Association between vitamin D and age-related macular degeneration in the Third National Health and Nutrition Examination Survey, 1988 through 1994, Arch Ophthalmol, 125, 661, 10.1001/archopht.125.5.661
Gouni-Berthold, 2009, Vitamin D and cardiovascular disease, Curr Vasc Pharmacol, 7, 414, 10.2174/157016109788340686
Judd, 2009, Vitamin D deficiency and risk for cardiovascular disease, Am J Med Sci, 338, 40, 10.1097/MAJ.0b013e3181aaee91
Bouillon, 2009, Vitamin D as potential baseline therapy for blood pressure control, Am J Hypertens, 22, 816, 10.1038/ajh.2009.105
Schmitz, 2009, Association of 25-hydroxyvitamin D with blood pressure in predominantly 25-hydroxyvitamin D deficient Hispanic and African Americans, Am J Hypertens, 22, 867, 10.1038/ajh.2009.88
Pilz, 2008, Association of vitamin D deficiency with heart failure and sudden cardiac death in a large cross-sectional study of patients referred for coronary angiography, J Clin Endocrinol Metab, 93, 3927, 10.1210/jc.2008-0784
de Boer, 2009, 25-Hydroxyvitamin D levels inversely associate with risk for developing coronary artery calcification, J Am Soc Nephrol, 20, 1805, 10.1681/ASN.2008111157
Tishkoff, 2008, Functional vitamin D receptor (VDR) in the t-tubules of cardiac myocytes: VDR knockout cardiomyocyte contractility, Endocrinology, 149, 558, 10.1210/en.2007-0805
Wu-Wong, 2007, VDR-mediated gene expression patterns in resting human coronary artery smooth muscle cells, J Cell Biochem, 100, 1395, 10.1002/jcb.21133
Autier, 2007, Vitamin D supplementation and total mortality: a meta-analysis of randomized controlled trials, Arch Intern Med, 167, 1730, 10.1001/archinte.167.16.1730
Lee, 2008, Vitamin D as an analgesic for patients with type 2 diabetes and neuropathic pain, Arch Intern Med, 168, 771, 10.1001/archinte.168.7.771
Xu, 2009, Mid- and late-life diabetes in relation to the risk of dementia: a population-based twin study, Diabetes, 58, 71, 10.2337/db08-0586
Miazgowski, 2008, Does type 2 diabetes predispose to osteoporotic bone fractures?, Endokrynol Pol, 59, 224
Zinman, 2010, Effect of rosiglitazone, metformin, and glyburide on bone biomarkers in patients with type 2 diabetes, J Clin Endocrinol Metab, 95, 134, 10.1210/jc.2009-0572
Boland, 1985, Presence of a 1,25-dihydroxy-vitamin D3 receptor in chick skeletal muscle myoblasts, Biochem Biophys Res Commun, 128, 305, 10.1016/0006-291X(85)91679-1
Bischoff-Ferrari, 2009, Prevention of nonvertebral fractures with oral vitamin D and dose dependency: a meta-analysis of randomized controlled trials, Arch Intern Med, 169, 551, 10.1001/archinternmed.2008.600